ArticleClinical drug investigation2023

Tumor Lysis Syndrome with CD20 Monoclonal Antibodies for Chronic Lymphocytic Leukemia: Signals from the FDA Adverse Event Reporting System.

Shuang Xia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.